# OnCo record paper-philip-j-clin-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-philip-j-clin-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-philip-j-clin-oncol" ;
  schema:name "Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study"@en ;
  schema:description "Paper cited by one trial page, indexed on Europe PMC as PubMed record 39088774 and published in Journal of Clinical Oncology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-philip-j-clin-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.23.02659>, <https://pubmed.ncbi.nlm.nih.gov/39088774/>, <https://europepmc.org/article/MED/39088774> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.23.02659> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Philip PA, Sahai V, Bahary N, et al." ;
  onco:trials <https://onco.cc/trials/avenger-500/> ;
  onco:journals <https://onco.cc/journals/jco/> .